Molecular pathology of lung cancer: key to personalized medicine.
10.3760/cma.j.issn.0529-5807.2012.10.019
- Author:
Liang CHENG
1
;
Yuan LI
;
Shao-bo ZHANG
;
Xiao-dong TENG
Author Information
1. Department of Pathology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. liang_cheng@yahoo.com
- Publication Type:Journal Article
- MeSH:
Antibodies, Monoclonal;
therapeutic use;
Antibodies, Monoclonal, Humanized;
Antineoplastic Agents;
therapeutic use;
Carcinoma, Non-Small-Cell Lung;
drug therapy;
genetics;
metabolism;
pathology;
Cetuximab;
Gene Rearrangement;
Humans;
Lung Neoplasms;
drug therapy;
genetics;
metabolism;
pathology;
Mutation;
Oncogene Proteins, Fusion;
genetics;
metabolism;
Phosphorylation;
Precision Medicine;
Proto-Oncogene Proteins;
genetics;
metabolism;
Proto-Oncogene Proteins B-raf;
genetics;
metabolism;
Proto-Oncogene Proteins p21(ras);
Receptor Protein-Tyrosine Kinases;
genetics;
metabolism;
Receptor, Epidermal Growth Factor;
genetics;
metabolism;
ras Proteins;
genetics;
metabolism
- From:
Chinese Journal of Pathology
2012;41(10):715-720
- CountryChina
- Language:Chinese
